Search results
An Nvidia Correction Might Be Inevitable. Here Are 3 Artificial Intelligence (AI) Stocks I'd Buy...
Motley Fool via Yahoo Finance· 3 hours agoMSFT PE ratio (forward) data by YCharts. PE = price to earnings. Microsoft's stock seems like a...
Nikola's Stock Is Slumping. Its Board Made a Grim Decision.
The Motley Fool via AOL· 58 minutes agoThere are two obvious ways for a company to get back into compliance: Announce news that sends the ...
Got $500 to Invest in Stocks? Put It in This Index Fund
The Motley Fool via AOL· 6 hours agoThis investment also allows you to diversify across industries. ...the fund. So, an investment in...
Stock Market Today: Stocks extend run; Nvidia world's most-valuable
TheStreet.com· 7 hours agoStocks are set to extend their recent run of record highs Thursday as big tech continues to push markets into uncharted territory. U.S. stocks moved higher in early Thursday trading, powered ...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 4 hours agoSupported by robust data from two Phase 3 clinical trials, INSPIRE and COMMAND, the approval highlights Skyrizi’s potential to become a cornerstone therapy in AbbVie’s portfolio, particularly ...
Where Will GoPro Be in 1 Year?
Motley Fool via Yahoo Finance· 4 days agoThe bad news about GoPro GoPro's cameras are pretty cool, but the...That's a big problem for GoPro, because one of its key initiatives is to expand its...
Best CD rates today: Hello summer and sunny savings with APYs of up to 5.40% — June 20, 2024
AOL· 5 hours agoHow to compare CDs When choosing the best certificate of deposit for your budget, compare these key...
Should You Be Adding Dycom Industries (NYSE:DY) To Your Watchlist Today?
Simply Wall St. via Yahoo Finance· 3 hours agoWhile opting for stocks without growing earnings and absent insider buying can yield results, for...
News Corp advances stock repurchase program By Investing.com
Investing.com· 3 days agoNews Corporation has announced progress in its ongoing stock repurchase program, which has been...
Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock
The Mammoth Times· 7 days ago(Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced the ...
